321 filings
Page 4 of 17
6-K
rreb5
2 Sep 21
BELLUS Health to Present at the H.C. Wainwright Global Investment Conference
7:00am
6-K
5d8ve050xxty4rxr
23 Aug 21
BELLUS Health to Report Additional RELIEF Data in an Oral Presentation at the European Respiratory Society International Congress 2021
7:00am
6-K
bozm24aklkllf1j3o
11 Aug 21
Condensed Consolidated Interim Financial Statements of
4:43pm
6-K
9joohe2fy2kg60
11 Aug 21
BELLUS Health Reports Second Quarter 2021 Financial Results and Business Highlights
4:31pm
6-K
a5p 0vlxz
25 May 21
BELLUS Health to Participate in the Jefferies Virtual Healthcare Conference
7:00am
6-K
y01ft7ai4 yrvc2cnajg
12 May 21
BELLUS Health to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
7:00am
6-K
jby1 qo06n3xa8t
10 May 21
Condensed Consolidated Interim Financial Statements of
4:48pm
6-K
3mj2k9
10 May 21
BELLUS Health Reports First Quarter 2021 Financial Results and Business Highlights
4:30pm
6-K
5t1fjh6r57hr4f2ro
10 May 21
BELLUS Health to Present at the American Thoracic Society 2021 International Conference
7:03am
6-K
5rgu m5rgrzn982tg
13 Apr 21
BELLUS Health to Present at the Bloom Burton & Co. Healthcare Investor Conference
7:00am
6-K
4yg cgbqn30
9 Apr 21
Notice of Annual Meeting of Shareholders
12:00am
6-K
ovyr44309mi7c
8 Apr 21
Bellus HEALTH 2020 ANNUAL REPORT
10:16am
6-K
00z3 ai0034lkg
24 Mar 21
BELLUS Health Appoints William Mezzanotte, MD, MPH to its Board of Directors
7:00am
6-K
erjxw8 2tn
5 Mar 21
Report of Foreign Private Issuer for the Month of March 2021
11:43am
6-K
go52a ptzifrn
25 Feb 21
BELLUS Health Reports Year 2020 Financial Results and Business Highlights
4:02pm
6-K
rjp9wjgkpngu zs78gg
22 Feb 21
BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences
7:00am
6-K
tprj 4bxnsf1c3ygg0
14 Jan 21
Bellus Health Inc. 6-K
7:00am
6-K
5p56z9x 5hmbka88bfw3
23 Dec 20
Open Market Sale Agreementsm
5:06pm
6-K
0oh0q2c0qbd qxy385
14 Dec 20
Bellus Health Inc. Form 6-K
7:01am
6-K
es2ov
8 Dec 20
BELLUS Health Announces First Patient Dosed in its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am